Google AI
The Times Australia

Times Media

Novo Nordisk Gulf receives prestigious Best Places to Work Certification in Kuwait, Qatar, Bahrain, and Oman for 2024

KUWAIT CITY, KUWAIT - Media OutReach Newswire - 2 October 2024 – Novo Nordisk Gulf, a leading global healthcare company, has been recognized as one of the Best Places to Work for 2024 across Kuwait, Qatar, Bahrain, and Oman.
This certification highlights the company's dedication to fostering a supportive, innovative, and inclusive work environment for its employees while remaining committed to its mission of driving change to defeat serious chronic diseases.

During the certification process, Novo Nordisk Gulf received high ratings in key areas including employee engagement, leadership support, and workplace culture. These factors underscore the company's success in creating a desirable workplace that aligns with its broader goal of improving health outcomes across the Gulf region.

Venkat Kalyan, Vice President & General Manager of Novo Nordisk Gulf Cluster, expressed his pride in the achievement: "We are honoured to receive the Best Place to Work recognition for Novo Nordisk Gulf Cluster. Our purpose is driving change to defeat serious chronic diseases, and this recognition serves as a testament of our commitment to this purpose, as well as our colleagues' valuable efforts to build and sustain an innovative and inclusive workplace."

Aydogan Cantimur, People & Organization Director at Novo Nordisk Gulf Cluster, also commented on the company's achievement: "In Novo Nordisk Gulf Cluster, we are committed to 'be the best workplace' by continuously evolving our environment to the better and creating the best employee experience by implementing tangible and innovative HR practices. We are proud to be recognized as a Best Place to Work in Gulf Cluster again, which gives us the confidence that we are on the right track."
Hashtag: #BestPlacesToWork

The issuer is solely responsible for the content of this announcement.

About Novo Nordisk

Novo Nordisk is a global healthcare company with over 95 years of innovation and leadership in diabetes care. Headquartered in Denmark, Novo Nordisk also leads in hemophilia care, growth hormone therapy, and hormone replacement therapy. The company employs approximately 70,000 people in 80 countries and markets its products in more than 170 countries.

For more information about Novo Nordisk and its commitment to the well-being of its employees and patients, visit .

For more information, please visit .

LinkedIn:

Twitter:

Facebook:

Times Magazine

Melbourne Local Steps Outside Her Comfort Zone to Compete for Miss World Australia 2027

From working in Melbourne real estate, building a career and now stepping into the Miss World Prel...

Award-Winning Author Cara Barilla Writes I Pray for My Teachers to celebrate Sydney Catholic Schools

Following her recognition as the winner of the 2024 Christian Literature Book Awards, Australian aut...

Technology

MISSION 1, MISSION 1 PRO and MISSIO…

Today, GoPro, Inc. (NASDAQ: GPRO) announced that its MISSION 1 Series of compact cinema cameras ha...

Local News

Fitstop Global Games to Bring 1,000…

The Australian-born fitness brand is bringing its global competition home, with athletes from across...

Culture

We cannot stop ageing. We can look after the …

Health care can sometimes buy us more time. Beauty treatments can change how we look. The most use...

Travel

School holiday pricing: fair market economics…

Every Australian family with school-aged children knows the pattern. Look at an airfare, hotel ro...

The Times Features

We cannot stop ageing. We can look after the life we ha…

Health care can sometimes buy us more time. Beauty treatments can change how we look. The most use...

The moving dollar: why Australia’s exchange rate is bec…

As the Australian dollar slips against the US currency, import bills rise and some exporters gain ...

What to Consider When Choosing Assisted Living in Sydne…

There comes a point when managing everything at home starts taking more effort than it used to. Th...